# Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery

> **NCT00706667** · PHASE4 · TERMINATED · sponsor: **University of Zurich** · enrollment: 75 (actual)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Ferinject ®

## Key facts

- **NCT ID:** NCT00706667
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** Not being able to recuit sufficient patients due to a lack of complience
- **Last updated:** 2013-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00706667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00706667, "Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00706667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*